Innovafeed Pitch Deck: All 9 Slides + Teardown

The Industrialization of Biotechnology

Innovafeed’s Series D pitch deck, used to raise $250M in 2022, is a study in how to present a capital-intensive hardware and biotech business to institutional investors. At this stage, the company is no longer selling a dream; it is selling a proven industrial process and a secured pipeline of demand. The deck is remarkably short at only nine slides, suggesting it served as a high-level executive summary for a round led by sophisticated sovereign wealth and private equity funds like Temasek and QIA.

Slide 1: Title and Positioning

The cover slide establishes Innovafeed not just as an insect farm, but as a "biotechnology company and leading insect producer for animal and plant nutrition." The imagery of a lush river landscape reinforces the "natural and sustainable" messaging. By dating the deck 20.09.2022, the company anchors the presentation in a specific moment of their global expansion phase.

Slide 2: The Mission

Slide 2 frames the problem through the lens of global food security. It cites the need to feed 10 billion people by 2050. The mission is broken down into three pillars: feeding the world, combining sustainability (reducing carbon footprint), and performance (competitive solutions). This is a standard but necessary framing for ESG-focused investors, ensuring the company is seen as a systemic solution rather than a niche product.

Slide 3: Why Black Soldier Flies?

This slide serves as the "Why Now" and "Why This" component. It lists the biological advantages of the Black Soldier Fly (BSF). Key claims include a "30% increase in animal and plant growth performance" and "proven health benefits" such as reduced mortality. From a production standpoint, it highlights a shorter lifespan, higher feed efficiency, and resistance to diseases. The inclusion of a photo of the fly on a human finger helps demystify the "insect" aspect, making the technology feel approachable and manageable.

Slide 4: Products and Market Size

This is one of the most critical slides in the deck. It breaks the business down into three distinct revenue streams, each with a massive Total Addressable Market (TAM):

Protein: €48BN market for animal feed, with a projected €1BN human food market by 2027. Partners include Barentz, Cargill, ADM, and Auchan. · Oil: €24BN market as a plant-based oil alternative in animal feed, partnered with Cargill and Auchan. · Frass: €25BN market as a replacement for chemical fertilizers, partnered with Hello Nature and Monsieur Marguerite.

By totaling nearly €100BN in addressable markets, Innovafeed justifies the large Series D check size. The presence of logos like ADM and Cargill under "Global customers" provides immediate commercial validation.

Slide 5: The Proprietary Technology Platform

To defend its margins, Innovafeed must prove it has a moat. Slide 5 divides their expertise into three categories: Life Sciences (genetics and substrate optimization), Data Science (continuous operational improvement), and Hardware & Automation (vertical breeding and HVAC). The mention of a "Unique HVAC approach" is particularly important for an indoor farming operation, as energy costs for climate control are often the primary failure point for the industry.

Slide 6: Ambition and Track Record

This slide demonstrates execution. It tracks the company from inception in 2016 to a pilot plant in 2017 (1,000 tons/year) and a full-scale plant in 2020 (15,000 tons/year). The timeline extends to 2024 with the Decatur, IL flagship project in partnership with ADM, and mentions MOUs already in place for the US, EU, and Asia through 2030. This shows a clear, non-speculative path to global dominance.

Slide 7: The USA Flagship Site

Slide 7 focuses on the Decatur, Illinois facility to illustrate the "circular" industrial model. By co-locating with ADM’s largest corn facility, Innovafeed secures:

Up to 300,000 tons of corn byproducts (feedstock). · 27 MW of waste energy and recycled process water (utilities). · Off-take contracts with Cargill and ADM Petfood.

This slide is a masterclass in de-risking. It shows that the two biggest inputs (feed and energy) and the output (sales) are all secured by long-term contracts before the plant is even fully operational.

Slide 8: The Team and Backers

The founders—Clément Ray, Aude Guo, and Bastien Oggeri—are presented with elite pedigrees: McKinsey, HSBC, Rothschild, and top-tier French engineering schools (Centrale Paris, Ponts et Chaussées). The bottom of the slide is a "who's who" of late-stage investing, featuring Temasek, QIA, Creadev, and major banks like BNP Paribas and Societe Generale. The claim of €450m invested since inception signals that this is a well-capitalized, institutional-grade venture.

Slide 9: Impact and Scale

The final slide quantifies the ESG impact. It notes the current headcount of 300 employees and 54% female managers. More importantly, it projects the impact of each new plant: 500 jobs, 45kT of marine resources salvaged, and 57kT of CO2 avoided. This provides the "Impact ROI" for the Series D investors.

What Innovafeed Does Well

The deck excels at Industrial Symbiosis . By showing how they plug into existing ADM infrastructure, they solve the two biggest problems in insect farming: the cost of feedstock and the cost of heat. Most startups try to build everything in a vacuum; Innovafeed shows they are an integrated part of the global agricultural supply chain.

Furthermore, the Commercial Validation is undeniable. Listing Cargill and ADM not just as "potential partners" but as holders of "off-take contracts" (Slide 7) and "global customers" (Slide 4) removes the market adoption risk that usually plagues biotech startups.

What is Missing from the Deck

As a Series D deck, there are notable omissions that were likely covered in a separate data room or a more detailed appendix:

Unit Economics: There is no mention of the cost to produce one ton of protein versus the market price. While they mention "competitive solutions," the actual margin profile is absent. · Detailed Financials: There are no revenue charts, burn rate figures, or EBITDA projections. The deck relies entirely on market size and partnership logos to imply financial health. · The Ask: The deck does not explicitly state how much they are raising or how the funds will be allocated between the Decatur plant, R&D, and global expansion. · Competitor Analysis: The deck ignores other major players in the insect protein space (such as Ÿnsect or Protix), choosing instead to frame Innovafeed as the undisputed leader.

Founder Takeaways

Sell the infrastructure, not just the science. Innovafeed spends as much time talking about HVAC and automated transport as they do about fly genetics. For a $250M round, investors need to see that you can build and operate massive factories, not just succeed in a lab.

Secure the supply chain. The most impressive part of this deck is Slide 7. If you are in a capital-intensive industry, showing that you have secured your raw materials and your energy via "waste" streams from a partner is the ultimate way to prove sustainability and cost-efficiency simultaneously.

Use logos as a shield. When you have partners like Temasek, ADM, and Cargill, you don't need 50 slides. The social proof does the heavy lifting. If you have major pilots or off-take agreements, they should be the centerpiece of your deck, not buried in the appendix.